Join us today for the August session of CDC Public Health Grand Rounds, “Primary Prevention and Public Health Strategies to Prevent Neonatal Abstinence Syndrome.” This session will be available via live webcast from CDC headquarters in Atlanta, Georgia today at 1 p.m. (EDT).
Neonatal Abstinence Syndrome (NAS) is a growing problem in the United States. NAS occurs when newborn babies experience withdrawal after being exposed to drugs in the womb. NAS can cause low birth weight and other complications leading to prolonged hospitalization. NAS can occur with a variety of both illicit and prescription drugs, including some prescription painkillers. The rates of NAS increased 5 times between the year 2000 and the year 2013. As of 2012, there was an average of one infant born with NAS every 25 minutes in the United States, accounting for an estimated $1.5 billion in healthcare spending that year alone.
Fortunately, NAS is preventable if an expectant mother receives proper care and treatment. One of the most effective prevention strategies is to improve preconception health care, and to educate both patients and providers about appropriate use of prescription drugs during pregnancy. Though there have been some recent initiatives to reduce rates of opioid use, few have included a focus on pregnant women and their babies. Screening of pregnant women can also be an effective prevention strategy by determining who may need additional care or treatment for opioid use.
In this session of Public Health Grand Rounds, you will hear how CDC is working with state and local partners to develop better policies for opioid prescribing among pregnant women. You will also hear how providers and patients can work together to prevent NAS by learning more about the choices that they make.
Future Grand Rounds topics include point-of-care newborn screening and new technologies for diagnosing foodborne illness.
Email your questions about this topic before or during the session. Follow us on Twitter #cdcgrandrounds
CDC’s Public Health Grand Rounds Presents:
“Primary Prevention and Public Health Strategies to Prevent Neonatal Abstinence Syndrome”
Tuesday, August 16, 2016
1:00 p.m. – 2:00 p.m. EDT
Global Communications Center (Building 19)
Alexander D. Langmuir Auditorium
Wanda Barfield, MD, MPH
CAPT, U.S. Public Health Service
Director, Division of Reproductive Health
National Center for Chronic Disease Prevention and Health Promotion, CDC
“The Problem of Neonatal Abstinence Syndrome”
Cheryl S. Broussard, PhD
Health Scientist, Birth Defects Branch
National Center on Birth Defects and Developmental Disabilities, CDC
“Beyond the Tip of the Iceberg: NAS Prevention and Preconception Health”
Kimberly A. Yonkers, MD
Director, Center for Wellbeing of Women and Mothers
Professor, Psychiatry, Epidemiology, Obstetrics, Gynecology, and Reproductive Sciences
Yale University School of Medicine
“Prescription Opioid and Substance Use in Pregnancy: Screening and Treatment”
Stephen W. Patrick, MD, MPH, MS
Assistant Professor, Pediatrics and Health Policy
Division of Neonatology
Vanderbilt University School of Medicine
“Using Hospital, State, and Federal Policies to Improve Care to Families Affected by NAS”
John Iskander, MD, MPH, Scientific Director, Public Health Grand Rounds
Phoebe Thorpe, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds
Susan Laird, MSN, RN, Communications Director, Public Health Grand Rounds
For non-CDC staff interested in viewing the session:
A live external webcast will be available via the Webcast Links section of our website. For individuals who are unable to view the session during the scheduled time, a video of the session will be posted to our archives 2-3 days after the presentation.
For non-CDC staff who wish to attend in person:
Due to security measures at CDC’s Roybal campus, non-CDC staff who wish to attend these sessions in person must have prior clearance and a U.S. state-issued photo ID (e.g., driver’s license, US passport). Names of non-CDC staff (both domestic and international) who wish to attend in person should be submitted to the Grand Rounds Team. Please note that all information for international visitors must be submitted at least 10 business days in advance.
For individuals requiring reasonable accommodations:
It is the policy of CDC to provide reasonable accommodations (RA) for qualified individuals with disabilities to ensure their full inclusion in CDC-sponsored events. Employees are asked to submit RA requests at least 5 business days prior to the event. Please e-mail the request to email@example.com.
Grand Rounds is available for Continuing Education.
ALL Continuing Education hours for Public Health Grand Rounds (PHGR) are issued online through the CDC/ATSDR Training and Continuing Education Online system. If you have questions, e-mail or call Learner Support at 1-800-418-7246 (1-800-41TRAIN).
Those who attend PHGR either in person, Envision, IPTV, or “web on demand” and who wish to receive continuing education must complete the online seminar evaluation. Thirty days from the initial seminar the course number will change to WD2346 and will be available for continuing education until February 18, 2018. The course code for PHGR is PHGR10.
Target Audience: Physicians, nurses, epidemiologists, pharmacists, veterinarians, certified health education specialists, laboratorians, others
- List key measures of burden of disease involving morbidity, mortality, and/or cost.
- Describe evidence-based preventive interventions and the status of their implementations.
- Identify one key prevention science research gap.
- Name one key indicator by which progress and meeting prevention goals is measured.
CE certificates can be printed from your computer immediately upon completion of your online evaluation. A cumulative transcript of all CDC/ATSDR CE’s obtained through the TCE Online System will be maintained for each user. We hope that this will assist CDC staff and other public health professionals to fulfill the requirements for their professional licenses and certificates.
Learn more about continuing education on the Grand Rounds website.